Technical Analysis for PODD - Insulet Corporation

Grade Last Price % Change Price Change
F 175.22 -2.47% -4.43
PODD closed down 2.47 percent on Friday, April 12, 2024, on 77 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Weak + Overbought Other 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Crossed Above 50 DMA Bullish -2.47%
Doji - Bearish? Reversal -2.47%
Multiple of Ten Bearish Other -2.47%
Weak + Overbought Other -2.47%
Weak, Overbought and Reversal Signs Reversal -2.47%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Insulet Corporation Description

Insulet Corporation, a medical device company, engages in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: S&P 500 Medicine Pharmaceutical Diabetes Medical Equipment Telehealth Telemedicine Glucose Insulin Endocrine System Diabetes Mellitus Endocrinology Durable Medical Equipment Treatment Of Diabetes Diabetes Management Infusion Systems Insulin Dependent Diabetes Insulin Pump

Is PODD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 335.91
52 Week Low 125.82
Average Volume 883,213
200-Day Moving Average 194.34
50-Day Moving Average 177.26
20-Day Moving Average 169.14
10-Day Moving Average 170.56
Average True Range 5.88
RSI (14) 53.27
ADX 18.55
+DI 27.14
-DI 17.42
Chandelier Exit (Long, 3 ATRs) 165.85
Chandelier Exit (Short, 3 ATRs) 179.33
Upper Bollinger Bands 178.96
Lower Bollinger Band 159.31
Percent B (%b) 0.81
BandWidth 11.62
MACD Line -0.20
MACD Signal Line -2.19
MACD Histogram 1.9898
Fundamentals Value
Market Cap 12.24 Billion
Num Shares 69.8 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 102.47
Price-to-Sales 8.82
Price-to-Book 22.13
PEG Ratio 0.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 181.78
Resistance 3 (R3) 182.14 180.32 180.69
Resistance 2 (R2) 180.32 178.65 180.14 180.32
Resistance 1 (R1) 177.77 177.61 176.86 177.41 179.96
Pivot Point 175.94 175.94 175.49 175.76 175.94
Support 1 (S1) 173.39 174.27 172.48 173.03 170.48
Support 2 (S2) 171.57 173.24 171.39 170.12
Support 3 (S3) 169.02 171.57 169.75
Support 4 (S4) 168.66